Table 3.
Primary outcomes in infants <30 gestation weeks and infants 30–32 gestation weeks.
| HD (N = 279) | LD (N = 304) | Adjusted risk ratio (95% CI) | P-between groups | ||
|---|---|---|---|---|---|
| Infants <30 gestation weeks | N = 143 | N = 169 | |||
| NEC | N (%) | 5 (3.5) | 4 (2.4) | 0.56 (0.16, 1.99) | 0.369 |
| Death | N (%) | 10 (7.0) | 9 (5.3) | 0.73 (0.30, 1.73) | 0.486 |
| NEC and/or Death | N (%) | 13 (9.1) | 11 (6.5) | 0.67 (0.31, 1.43) | 0.303 |
| Infants ≥30 gestation weeks | N = 136 | N = 135 | |||
| NEC | N (%) | 2 (1.5) | 0 (0.0) | na | na |
| Death | N (%) | 1 (0.7) | 2 (1.5) | 1.97 (0.20, 19.90) | 0.565 |
| NEC and/or death | N (%) | 3 (2.2) | 2 (1.5) | 0.66 (0.12, 3.68) | 0.634 |
Adjusted by gestational age and sex.
HD high dose, LD low dose, N number of patients, NEC Necrotizing enterocolitis Bell stage IIb or higher, na not applicable.